The effectiveness of tirzepatide for treating obesity is being evaluated in the SURMOUNT series of phase 3 RCTs, which, for the first time, demonstrated average weight reductions exceeding 20% with pharmacotherapy [23]
Issued in Switzerland by William Blair Investment Services (Zurich) GmbH, Talstrasse 65, 8001 Zurich, Switzerland ("WBIS")
I mean, look how thin this needle is
This wasnt just a small snack
The studies showed that treatment reduced body weight gain by over 50% compared to controls over a 19-day period, with increased lipolytic activity specifically in adipose tissue deposits
Cada cpsula aporta un apoyo integral para fortalecer el bienestar diario y promover una respuesta saludable del cuerpo ante las demandas cotidianas